Jo M Berger, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2200 Commerce Blvd, Mound, MN 55364 Phone: 952-495-2000 Fax: 952-495-2060 |
News Archive
A recent study led by Gergely Lukacs, a professor at McGill University's Faculty of Medicine, Department of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene product responsible for cystic fibrosis (CF) requires correcting two distinct structural defects. This finding could point to more effective therapeutic strategies for CF in the future.
Nabi Biopharmaceuticals announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc. for the manufacture of Drug Substance integral to the production of NicVAX, Nabi's innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse.
According to a recent study in Perth, Australia, babies here are being fed high calorie junk foods like biscuits, cakes, hot chips and ice cream before they turn one. This practice affects their eating habits for life say researchers. The report appeared in the Australian Journal of Nutrition and Dietetics. The study was undertaken by the Telethon Institute of Child Health Research, University of Western Australia and Curtin University and South Australia's Flinders University.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of the Guide-it CRISPR/Cas9 Gesicle Production System. This system provides an innovative method to deliver Cas9/single guide RNA (sgRNA) ribonucleoprotein complexes to a broad range of cell types.
› Verified 5 days ago